Cargando…

Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers

BACKGROUND AND AIM: Oxidative stress leads to a compensatory increase in levels of serum ceruloplasmin in patients with such imbalances. Greater than normal serum ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin's lymphoma. The purpose of the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Manisha B., Lavanya, T., Kumari, C. Meena, Shetty, Shishir Ram, Gufran, Khalid, Viswanath, Vipin, Swarnalatha, C., Babu, J. Suresh, Nayyar, Abhishek Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531576/
https://www.ncbi.nlm.nih.gov/pubmed/34729047
http://dx.doi.org/10.4103/jcar.jcar_10_21
_version_ 1784586889394651136
author Patil, Manisha B.
Lavanya, T.
Kumari, C. Meena
Shetty, Shishir Ram
Gufran, Khalid
Viswanath, Vipin
Swarnalatha, C.
Babu, J. Suresh
Nayyar, Abhishek Singh
author_facet Patil, Manisha B.
Lavanya, T.
Kumari, C. Meena
Shetty, Shishir Ram
Gufran, Khalid
Viswanath, Vipin
Swarnalatha, C.
Babu, J. Suresh
Nayyar, Abhishek Singh
author_sort Patil, Manisha B.
collection PubMed
description BACKGROUND AND AIM: Oxidative stress leads to a compensatory increase in levels of serum ceruloplasmin in patients with such imbalances. Greater than normal serum ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin's lymphoma. The purpose of the present study was to estimate and evaluate the efficacy of serum ceruloplasmin levels as a potential biomarker in the early detection of oral potentially malignant epithelial lesions (PMELs) including leukoplakia, oral submucous fibrosis (OSMF), and oral squamous cell carcinoma (OSCC) patients. MATERIALS AND METHODS: The present observational study was conducted over a period of 2 years wherein 100 subjects aged between 18 to 60 years were divided into four groups with Group A consisting of 25 healthy controls, Group B and C with 25 patients each, clinically diagnosed with oral leukoplakia and OSMF and Group D with 25 patients clinically diagnosed and histopathologically proven OSCC. The patients were subjected to incisional biopsy after routine hematological investigation while the same sera samples were used for analysis of serum ceruloplasmin levels. STATISTICAL ANALYSIS USED: Comparison of serum ceruloplasmin levels between the groups was performed using one way analysis of variance (one way ANOVA) test while P < 0.05 was considered statistically significant. RESULTS: The mean serum ceruloplasmin levels were found to be 43.19 ± 1.90mg/dl in subjects of group A, 47.68 ± 1.51mg/dl in group B, 47.74 ± 1.45mg/dl in group C and 47.73 ± 0.74mg/dl in group D. Using one-way ANOVA, statistically significant variations were found in the values of mean serum ceruloplasmin levels in subjects of the four groups (F-value = 59.58, P = 0.0001). CONCLUSIONS: The observations of the present study revealed that serum ceruloplasmin levels were found to be raised in all 3 study groups including oral leukoplakia, OSMF and OSCC as compared to the controls while the results were found to be statistically significant.
format Online
Article
Text
id pubmed-8531576
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-85315762021-11-01 Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers Patil, Manisha B. Lavanya, T. Kumari, C. Meena Shetty, Shishir Ram Gufran, Khalid Viswanath, Vipin Swarnalatha, C. Babu, J. Suresh Nayyar, Abhishek Singh J Carcinog Original Article BACKGROUND AND AIM: Oxidative stress leads to a compensatory increase in levels of serum ceruloplasmin in patients with such imbalances. Greater than normal serum ceruloplasmin levels are noticed in numerous cancers including the leukemias and Hodgkin's lymphoma. The purpose of the present study was to estimate and evaluate the efficacy of serum ceruloplasmin levels as a potential biomarker in the early detection of oral potentially malignant epithelial lesions (PMELs) including leukoplakia, oral submucous fibrosis (OSMF), and oral squamous cell carcinoma (OSCC) patients. MATERIALS AND METHODS: The present observational study was conducted over a period of 2 years wherein 100 subjects aged between 18 to 60 years were divided into four groups with Group A consisting of 25 healthy controls, Group B and C with 25 patients each, clinically diagnosed with oral leukoplakia and OSMF and Group D with 25 patients clinically diagnosed and histopathologically proven OSCC. The patients were subjected to incisional biopsy after routine hematological investigation while the same sera samples were used for analysis of serum ceruloplasmin levels. STATISTICAL ANALYSIS USED: Comparison of serum ceruloplasmin levels between the groups was performed using one way analysis of variance (one way ANOVA) test while P < 0.05 was considered statistically significant. RESULTS: The mean serum ceruloplasmin levels were found to be 43.19 ± 1.90mg/dl in subjects of group A, 47.68 ± 1.51mg/dl in group B, 47.74 ± 1.45mg/dl in group C and 47.73 ± 0.74mg/dl in group D. Using one-way ANOVA, statistically significant variations were found in the values of mean serum ceruloplasmin levels in subjects of the four groups (F-value = 59.58, P = 0.0001). CONCLUSIONS: The observations of the present study revealed that serum ceruloplasmin levels were found to be raised in all 3 study groups including oral leukoplakia, OSMF and OSCC as compared to the controls while the results were found to be statistically significant. Wolters Kluwer - Medknow 2021-09-30 /pmc/articles/PMC8531576/ /pubmed/34729047 http://dx.doi.org/10.4103/jcar.jcar_10_21 Text en Copyright: © 2021 Journal of Carcinogenesis https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Patil, Manisha B.
Lavanya, T.
Kumari, C. Meena
Shetty, Shishir Ram
Gufran, Khalid
Viswanath, Vipin
Swarnalatha, C.
Babu, J. Suresh
Nayyar, Abhishek Singh
Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
title Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
title_full Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
title_fullStr Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
title_full_unstemmed Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
title_short Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
title_sort serum ceruloplasmin as cancer marker in oral pre-cancers and cancers
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531576/
https://www.ncbi.nlm.nih.gov/pubmed/34729047
http://dx.doi.org/10.4103/jcar.jcar_10_21
work_keys_str_mv AT patilmanishab serumceruloplasminascancermarkerinoralprecancersandcancers
AT lavanyat serumceruloplasminascancermarkerinoralprecancersandcancers
AT kumaricmeena serumceruloplasminascancermarkerinoralprecancersandcancers
AT shettyshishirram serumceruloplasminascancermarkerinoralprecancersandcancers
AT gufrankhalid serumceruloplasminascancermarkerinoralprecancersandcancers
AT viswanathvipin serumceruloplasminascancermarkerinoralprecancersandcancers
AT swarnalathac serumceruloplasminascancermarkerinoralprecancersandcancers
AT babujsuresh serumceruloplasminascancermarkerinoralprecancersandcancers
AT nayyarabhisheksingh serumceruloplasminascancermarkerinoralprecancersandcancers